Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 15;25(1):2464.
doi: 10.1186/s12889-025-23628-w.

Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study

Affiliations

Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study

Ruixue Song et al. BMC Public Health. .

Abstract

Background: Prospective longitudinal studies have shown inconsistent effects of obesity phenotypes on the risk of cardiovascular disease (CVD) mortality. Also, longitudinal evidence from Chinese populations remained scarce. We aimed to investigate the association of obesity phenotypes assessed by body mass index (BMI) and metabolic syndrome (MetS) with risk of CVD mortality, leveraging the unique adiposity patterns and metabolic vulnerability of Asian populations.

Methods: A subset of 26,884 participants (aged 49.30 ± 10.37 years, 39.23% men) from Taizhou longitudinal study were followed up to 8 years. Obesity phenotypes were categorized into 4 groups including metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUNO) and metabolically unhealthy obese (MUO), using BMI categories from Chinese criteria (obesity: ≥28.0 kg/m²) and MetS defined by International Diabetes Federation (IDF) consensus. The death caused by CVD were identified based on international classification of diseases-10th Revision (ICD-10). Data were analyzed using the Cox regression models and Laplace regression models.

Results: Of 26,884 participants, 15,462 (57.5%), 1,702 (6.3%), 3,656 (13.6%) and 2,064 (7.7%) subjects were classified into the MHNO, MHO, MUNO and MUO group, respectively. At the end of the follow-up, 113 (0.39%) participants died because of CVD. Compared with the MHNO group, the hazards ratios (HRs) and 95% confidence intervals (CIs) of CVD mortality were 1.73 (1.03–2.91) and 1.97 (1.11–3.52) respectively in MUNO and MUO group. The multi-adjusted 50th percentile differences (50th PDs) (95% CIs) of time at incident CVD mortality in MUNO and MUO group were 0.97 (0.00-1.93) and 1.35 (0.31–2.39) years earlier respectively than those in MHNO group. MHO group showed no significant risk elevation (HR = 1.21, 0.68–2.17) despite the earlier 50th percentile differences of CVD mortality years (50th PD = 0.94, 95%CI: 0.38–2.25).

Conclusions: Metabolic abnormalities increased the risk of CVD mortality especially in participants with obesity.

Supplementary Information: The online version contains supplementary material available at 10.1186/s12889-025-23628-w.

Keywords: CVD mortality; Metabolic syndrome; Metabolically unhealthy non-obese; Metabolically unhealthy obese; Obesity phenotypes.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the ethics committee of the Taizhou Institute of Health Sciences, Fudan University. All the participants provided written informed consent before data collection. This research conformed to the principles of the Helsinki Declaration. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the study population
Fig. 2
Fig. 2
Forest plot for the association of obesity phenotypes with cardiovascular disease (CVD) mortality Adjusted for age, sex, education, smoking, alcohol consumption, physical activity and family history of heart diseaseAbbreviations: MHNO= Metabolically healthy non-obese, MHO= Metabolically healthy obese, MUNO= Metabolically unhealthy non-obese, MUO= Metabolically unhealthy obese

Similar articles

References

    1. WHO, Obesity. and Overweight. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
    1. Collaborators GBDAB. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813–38. 10.1016/S0140-6736(25)00355-1. - PMC - PubMed
    1. Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9:373–92. 10.1016/S2213-8587(21)00045-0. - PubMed
    1. Tian Y, Jiang C, Wang M, Cai R, Zhang Y, He Z, et al. BMI, leisure-time physical activity, and physical fitness in adults in china: results from a series of National surveys, 2000-14. Lancet Diabetes Endocrinol. 2016;4:487–97. 10.1016/S2213-8587(16)00081-4. - PubMed
    1. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European prospective investigation into Cancer and nutrition (EPIC)-Potsdam study. Am J Clin Nutr. 2006;84:427–33. 10.1093/ajcn/84.1.427. - PubMed

LinkOut - more resources